DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: These research avenues involve not only symptomatic treatments but also treatments such as exon skipping, myoblast transplantation, and gene editing, which treat the root cause of dysferlinopathy by restoring dysferlin protein expression.